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The serpins (serine proteinase inhibitors) are structurally similar but functionally diverse proteins that fold into a conserved
structure and employ a unique suicide substrate-like inhibitory mechanism. Serpins play absolutely critical role in the control
of proteases involved in the inﬂammatory, complement, coagulation and ﬁbrinolytic pathways and are associated with many
conformational diseases. Serpin’s native state is a metastable state which transforms to a more stable state during its inhibitory
mechanism.Serpininthenativeformis inthestressed (S)conformationthatundergoes a transitionto arelaxed (R) conformation
for the protease inhibition. During this transition the region called as reactive center loop which interacts with target proteases,
inserts itself into the center of β-sheet A to form an extra strand. Serpin is delicately balanced to perform its function with many
critical residues involved in maintaining metastability. However due to its typical mechanism of inhibition, naturally occurring
serpin variants produces conformationalinstability that allows insertion of RCL of one molecule into the β-sheet A of another to
form a loop-sheet linkage leading to its polymerization and aggregation. Thus understanding the molecular basis and amino acid
involved in serpin polymerization mechanism is critical to devising strategies for its cure.
1.Introduction
Serpins (serine proteinase inhibitors) are the largest super
family of protease inhibitors involved in many critical bio-
logical processes like blood coagulation, ﬁbrinolysis, pro-
grammed cell death, development and inﬂammation [1–
3]. Serpins are structurally heterogeneous and functionally
diverseproteins foundin theorganisms ranging from viruses
to vertebrates [4–6]. Over 400 diﬀerent serpins have been
identiﬁedinorganisms includingviruses, plants,insects,ani-
mals and prokaryotes [7]. Serpins like α-antitrypsin, α-anti-
chymotrypsin, C1-inhibitors, antithrombin, and plasmino-
gen activator inhibitor-1 (PAI), play absolutely critical role
in the control of proteases involved in the inﬂammatory,
complement, coagulation and ﬁbrinolytic pathways, respec-
tively, and are associated with diseases like emphysema/cir-
rhosis, angioedema, familial dementia, chronic obstructive
bronchitis and thrombosis [8]. Not all serpins act as prote-
inase inhibitors some are inhibitors of other types of pro-
teinases, while others are noninhibitors. For example, the
viral serpin crmA inhibits interleukin-1 converting enzyme
and squamous cell carcinoma, antigen-1 (SCCA-1) inhibits
cysteinyl proteinases of the papain family. Noninhibitory
serpins perform diverse functions, including roles as chap-
erones, for example, the 47-kD heat shock protein [HSP47]
and hormone transportation like cortisol-binding globulin
[7].
2.SerpinStructureand Common
Mechanism ofAction
There is a high rate of conservation in the structure among
the members of serpin family in which the average size of2 Journal of Amino Acids
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Figure 1: The scheme shown here (taking antithrombin as an example) represents the suicide substrate inhibition mechanism common
to all inhibitory serpins. The scheme represents the interaction between the serpin (antithrombin, ATIII) and protease (E); ATIII-E is the
noncovalentMichaeliscomplex; ATIII-E’istheproposedintermediatebeforepartitioning;ATIII-E∗ isthestableprotease-inhibitorcomplex;
ATIII∗ isthecleavedATIII.Theoutcomeofthereactionisdependentonthepartitioningbetween theinhibitory(kinh)andsubstratepathways
(ksub). The ﬁgures represent the cleaved and factor Xa bound ternary complexes of antithrombin [3].
protein is 350–400 amino acids and the molecular weight of
40–50kDa [4]. The serpin fold is comprised of 3-β sheets
(A, B, C) and 7–9 alpha helices. A solvent exposed stretch of
amino acids termed as reactive centre loop (RCL) contains
the protein recognition site which forms a ﬂexible stretch of
∼17 residues between β sheets A and C [8]. The mechanism
of inhibition of serpin has been demonstrated biophysically
and structurally as suicide substrate-like inhibitory mecha-
nism (as shown in Figure 1) where after binding to protease
it is partitioned between cleaved serpin and serpin-protease
complex [9]. Initially serpin binds to protease through a
noncovalent Michaelis-like complex by interactions with
residues ﬂanking the scissile bond (P1-P1 )[ 6]. Attack of the
active site serine on the scissile bond leads to a covalent ester
l i n k a g eb e t w e e nS e r - 1 9 5o ft h ep r o t e a s ea n dt h eb a c k b o n e
carbonyl of the P1 residue resulting in the cleavage of the
peptide bond. Protease speciﬁcity is determined by the P1-
P1  bond which is positioned such that it is readily accessible
to proteases, Table 1 shows the residues involved in P1-P1  in
variousserpins. RCLinserts intotheβ sheet Aandtransports
the covalently bound protease with it. As a result protease
gets translocated by over 70 ˚ A( Figure 1) and its active site
gets distorted [6, 8]. Distortion of the active site prevents
the ﬁnal hydrolysis events and the result is an irreversible
covalent serpin-enzyme complex. When active serpins are
proteolytically inactivated in a substrate-like reaction, they
undergo an important structural transition with a resultant
increase in their conformation stability [9]. The P4-P4 
sequence of RCL is highly conserved in all inhibitory serpins
and mutations in this region (P2 Gly to Pro mutation in
antithrombin) result in loss of inhibitory activity (Table 1).
Furthermore, the amino acids of the hinge region have
small side chain that allows loop ﬂexibility necessary for
complex formation. In contrast, the RCL of ovalbumin is
in a fully extended, rigid alpha-helical conformation that
is unable to conform to the active site of a protease which
explains its lack of inhibitory activity. The driving force for
this conformational change is thought to be the energy loss
associatedwiththeincreasedloopinsertioninthecomplexed
serpin.
3.Domains Involved inSerpin
Inhibition Mechanism
Several regions are important in controlling and modulating
serpin conformational changes; Figure 2 shows functionally
and structurally important regions of serpin [10]. A portion
of RCL from P15–P9 is called the hinge region [3, 11]. In
S → R transition it provides mobility which is vital for the
conformational change of the RCL. Hinge region contains
many conserved residues between P15–P10, towards the N-
terminal of the RCL. Out of these the amino acid at P14
(Ser-380) is of critical importance as its insertion in the
β-sheet A is a prerequisite for inhibitory activity [12]. In
antithrombin the replacement of P12 Ala by the Thr causes
loss of inhibitory activity which is due to polymerization of
antithrombin [13]. The breach region represents the point
of initial insertion of the RCL which is located at the top
of the A β-sheet [14]. Near the centre of A β-sheet is the
shutter domain [15]. The breach and shutter are two major
regions that assist sheet opening and accept the conserved
hinge of the RCL when it inserts [8]. Highly conserved
residues located in the shutter region of the β-sheet A of the
serpin fold are Ser-53 and Ser-56 which play an important
role in the serpin conformational transitions [16]. The gate
region is composed of s3C and s4C strands which has been
primarily observed by studies of the transition of active PAI-
1i n t ol a t e n c y[ 17]. In order to insert fully into the A β-sheetJournal of Amino Acids 3
Table 1: Represents the Scissile bond in various serpins and their protease targets. Antithrombin is an eﬃcient inhibitor of factor Xa,
thrombin and factor IXa. Residues ﬂanking the P1-P1  are also critical for protease multispeciﬁcity.
Scissile bond
Clade; Serpin P4 P3 P2 P1-P1 P2 P3 P4 Primaryt a rget
A1; α1-PI A I P M--S I P P Neutrophil elastase
A3; α1-ACT I T L L--S A L V Cathepsin G
A4; kallistatin I K F F--S A Q T Tissue kallikrein
A5; PCI F T F R--S A R L Activated protein C
   ITAY - - SMP P f Xa&f XIa
B1; MNEI A T F C--M L M P Neutrophil elastase
B2; PAI-2 M T G R--T G H G plasminogen activator
B3; SCCA1 G F G S--S P A S Cathepsin K, L & S
B6; PI6 M M M R--C A R F plasmin
C1; antithrombin III I A G R--S L N P IIa & fXa
D1; heparin cofactor II F M P L--S T Q V IIa
E1; PAI-1 V S A R--M A P E Plasminogen activator
E2; protease nexin 1 L I A R--S S P P Plasminogen activator
F2; α2-antiplasmin A M S R--M S L S plasmin
G1; C1-inhibitor SVAR - - T L L V C 1
I1; neuroserpin A I S R--M A V L Plasmin & plasminogen activator
A10; PZ
without cleavage, the RCL has to pass around the β-turn
linking strand s3C and s4C [10, 18].
4.Ligand-DependentSerpins
One of the important features of serpins is their ability to
bind various protease and nonprotease ligand (Table 2)a n d
some of the examples of ligand-dependent serpins are
antithrombin, heparin cofactor II, protein C inhibitor, plas-
minogen-activator inhibitor-1 (PAI-1), protease nexin-1 and
kallistatin [19]. Binding of ligand to these serpins regulate
their activity, like PAI-1 binds to vitronectin or ZPI binds
to protein Z [20]. Several serpins which interact with gly-
cosaminoglycan ligands have their reactions with proteases
improved by such ligands in accordance with a ternary com-
plex bridging mechanism. Vitronectin also seems to help
the reaction of PAI-1 with thrombin [21]. A subfamily of
serpins exists whose inhibitory activity is greatly accelerated
upon binding of heparin and other negatively charged
polyanions, such as heparan sulfate and dermatan sulphate.
The members of this group include heparin cofactor II
(HCII), antithrombin, protein C inhibitor, protease nexin 1
(PN-1) and PAI-1. Heparin is a highly negatively charged
glycosaminoglycan consisting of alternating glucosamine
and iduronic acid monomers. Studies have demonstrated
that upon binding to heparin antithrombin gets activated.
Binding of heparin pentasaccharide to the D helix of anti-
thrombin causes a series of large conformational shifts (as
shown in Figure 3). Extension of D-helix at both the ends
leads to an interdomain rotation of the bottom half of
the antithrombin relative to the top half, which leads to
RCL expulsion from the β-sheet A and exposure of the P1
arginine (Arg-393) residue [18, 22]. The basic residues in
this site that interact with the pentasaccharide are Lys-11
and Arg-13 in the N-terminal end; Arg-46 and Arg-47 in
the A-helix; and Lys-114, Lys-125, and Arg-129 in the region
of the D-helix (Figure 3). Two nonbasic residues, Phe-121
and Phe-122, reside near these positively charged amino
acids of the heparin-binding domain but make minimal
direct contact with the pentasaccharide sequence [23]. It has
been shown that mutation of either Phe-121 or Phe-122
leads to decline in antithrombin-heparin binding aﬃnity.
Cofactor binding serpins are critically balanced to maintain
itsnativemetastabilityduringitsbindingandtransformation
of conformational change (Figure 3).
5.SerpinMetastableForm
T h em e t a s t a b l en a t i v es t a t eo fs e r p i n si st h o u g h tt ob el i k ea
kinetically trapped folding intermediate that is blocked by a
very high kinetic barrier [24, 25]. The study of this kinetic
trap provided an important link to understand structure-
function relationships of serpins but the molecular basis by
which this kinetic trap prevents the native serpin to form a
more stable state is unknown [26]. It has been suggested that
there are certain native interactions in the metastable form
which drags it to get converted into a more stable form [24].
Studies have shown that the other stable conformation in
the native serpin chain is the latent RCL-inserted form [17,
27]. For example the native form of a serpin, plasminogen
activator inhibitor-1, readily gets transitioned into the latent
form under physiological conditions with a half-life of 1-2
hours [28] and same happens in other serpins under mild
denaturing conditions [29].
In serpins, when RCL is inserted into the A β-sheet,
t h e r eo c c u rag r a d u a ld e c l i n ei nt h ef r e ee n e r g yo ft h es e r p i n
and an increase in its stability [30–32]. Surprisingly, serpins
also undergo a rise in thermostability when complexed with4 Journal of Amino Acids
Table 2: Serpins and their known protease and nonprotease ligands.
Serpin Non protease ligands Protease target
Antithrombin Heparin, heparin sulfate Thrombin, factor Xa, factor IXa
Antichymotrypsin DNA, Aβ1−42peptide Cathepsin G
Alpha-1 Proteinase inhibitor — Neutrophil elastase
C1-Inhibitor Heparin, collagen Cls of complement system
Headpin — Lysosomalcathepsin
Heparin CofactorII Heparin, dermatan sulfate Thrombin
HSP47 Collagen —
Kallistatin Heparin Tissue Kallikerin
Maspin Collagen —
MENT DNA Nuclear cysteine proteinase
PlasminogenActivator inhibitor-1 Heparin, heparin sulfate, vitronectin tPA, uPA, thrombin, aPC
Protein C inhibitor Heparin, retinoic acid uPA, thrombin, aPC
Protease nexin-1 Heparin, collagen Thrombin uPA
Thyroxine Binding Globulin Thyroxine, triiodothyronine —
Protein Z dependent protease inhibitors (ZPI) Protein Z Factor Xa
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Figure 2: Important domains in serpin conformations. Several re-
gions are important in controlling and modulating serpin confor-
mational changes. The Reactive Centre Loop is involved in protease
recognition and conformational transformation as strand 4A after
inhibition. The P15–P9 portion of the RCL is called the hinge
region. The point of initial insertion of the RCL which is the breach
region, located at the top of the A β-sheet. Near the center of A β-
sheet is the shutter domain. The breach and shutter are two major
regions that assist sheet opening and accept the conserved hinge of
the RCL when it inserts. The gate region is composed of s3C and
s4C strands which has been primarily observed by studies of the
transition latency. The image was drawn in chimera using the PDB
ﬁle of native antitrypsin conformation.
peptides analogous to the RCL [33]. This suggests that in-
creased stability is a product of hydrogen bond formation
and hydrophobicinteractionsmadebytheadditionofasixth
strand to the A β-sheet as s4A. But the negative consequence
of obtaining metastability is that serpins are vulnerable to
mutations that can result in aberrant structural rearrange-
ment into dysfunctional states with increased stability [34].
6.The Molecular Basisof SerpinMetastability
Native state of the serpin is dependent on nonideal interac-
tions (Table 3) which imparts strain within the native fold
that can be further alleviated by adopting alternative con-
formations [35]. Nonideal interactions include the presence
of hydrophobic pockets [36, 37], overpacking of side-chains
[38], and the burial of polar groups [39] and cavities in the
hydrophobic core of the protein [40]. Molecular details of
how such structural defects control the protein functions
are yet to be elucidated. Native conformation regulates the
inhibitory function of α-1 antitrypsin by controlling the rate
oftheconformationalswitchduringcomplexformationwith
a target protease. Hence the conformational switch is driven
by mobilization of unfavourable interactions in the native
state into more favourable ones, such interactions seem to
have control over conformational switch [41]. From ﬂuo-
rescence studies it has been identiﬁed that nonnative inter-
actions were residing around the top of the A β-sheet and
the F-helix [42, 43]. Some unfavourable interactions that are
involved in maintaining the metastable state of antitrypsin
are summarized in Table 3. The unfavourable interactions
made by residues of the F-helix might play a crucial role
in preventing incorrect folding in serpin [35, 44]. Lys-335
is suitably situated near the F-helix to assist in the sheet
A opening where it forms critical interaction with Ile-169
and Leu-172, a reduction in the side chain of these residuesJournal of Amino Acids 5
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Figure3:Conformationalchangesincofactor(heparin)boundserpin(antithrombin)andresiduesinvolvedincofactorinteraction.Heparin
binding produces a series of conformational changes in antithrombin; extension of helix D by forming a 2 turn helix (P-helix) at the
N-terminal end and a 1.5 turn extension of D-helix towards the C-terminal end. Moving of strand 3A and strand 5A and expulsion of
reactive center loop leads to activated antithrombin. Given below are the basic residues in the heparin binding site that interact with the
pentasaccharide are Lys-11 and Arg-13 in the N-terminal end; Arg-46 and Arg-47 in the A-helix; and Lys-114, Phe-121, Phe-122, Lys-125,
andArg-129intheregionoftheD-helix.TheﬁguresweremadebyusingantithrombinPDB(native1E05;activated 1E03)ﬁlesandswiss-prot
PDB viewer.
results in increase in stability which contributes in the native
strain. Polar-nonpolar interactions also contribute to native
stability, Phe-189 interacts with Gly-164 and Thr-165 in
the F-helix providing unfavourable interaction which con-
tributes in native metastability [40].
Serpins make use of many conserved interactions which
aredistributedaroundthemoleculetostayinthekinetictrap
until a protease comes along and initiates further thermody-
namically favourableconformational changes [44]. Decreas-
ing the size of side chains in overpacked regions releases
the native strain, and increasing the size of side chains in
cavities stabilizes the native form, probably by providing
better interactions with nearby residues. Likewise, ﬁlling
exposed hydrophobic pockets by substituting larger residues
also stabilizes the native state in antitrypsin [40]. Such un-
favourable structural features are also found in other serpin
proteins, like antichymotrypsin and antithrombin III, and
the native strain in these serpins can also be relieved by
compensating substitutions [45]. During protease inhibitor
complex formation, unfavourable interactions in the native
form are mobilized and transformed into more favourable
ones [3]. These conformational changes result in the conver-
s i o no ft h em e t a s t a b l en a t i v ef o r mi n t oam o r es t a b l ec o n -
formation [46].6 Journal of Amino Acids
Table 3: Unfavourable interactions that contribute to the metasta-
bility of the native antitrypsin. Nonideal interactions include the
presence of hydrophobic pockets, overpacking of side-chains, the
burial of polar groups, cavities in the hydrophobic core of the
protein and polar nonpolar interactions [40]. Lys-335 is one of the
residues in antitrypsin that has been shown to play a crucial role
in conformational switch during the process of inhibition. Local
strain due to Lys-335 interactions in the native state is critical for
the inhibitory activity.
Over packing
of side chains
Polar-nonpolar
interactions
Cavity ﬁlling
mutations
Favourable
interactions
Lys-335 Phe-189—Gly-
164 Gly164Val
Native
(Lys-335 is
buried)
Ile-169
Thr-165-Val-
161 Ala183Val Cleaved
Thr-165-Ile-169
Lys-335 forms
salt bridge with
Asp-171
Leu-172
Leu-172-Asn-
186 Thr114Phe Ile-169
Lys-331-Val-333 Gly117Phe Lys-168-Glu-346
(salt bridge)
7.SerpinPolymerization
The tendency of the RCL of serpins to become an additional
strand in a pre-existing β-sheet also makes them prone to
other types of loop-sheet interactions [47]. As a protein
family, serpins are particularly prone to the formation of
stable polymers owing to the metastability of their native
fold and the thermodynamically driven β sheet opening out
mechanism required for their role as protease inhibitors
[3, 6]. Approximately −32kcal /mol energy is released by
the incorporation of the reactive centre loop (RCL) of the
serpinintothecentreofitsmainβ-sheet [48].Figure 4shows
point mutation in some representative serpins that leads to
dimerization, aggregation and polymerization.
Severe deﬁciency of the Z variant of α-1-antitrypsin
(Glu342Lys) results from a conformational switch and forms
a unique linkage between the reactive centre loop of one
molecule and A β sheet of a second [49]. This process
of polymer formation was dependent on temperature and
concentration, and the polymers that were formed had the
appearance of “beads on a string” when seen by electron
microscopy [49, 50]. Since this initial report, investigations
have been concerned with the characterization and classi-
ﬁcation of clinically relevant mutations. Neuroserpin is a
member of the serine proteinase inhibitor (serpin) super-
family that is secreted from the growth cones of neurons and
inhibits the enzyme tissue type plasminogen activator (tPA)
[51]. Aberrant protein linkage in mutants of neuroserpin
causes intracerebral inclusions and dementia. Four diﬀerent
mutations of neuroserpin (Ser49Pro, Ser52Arg, His338Arg
and Gly392Glu) have been described in humans [52–54]. All
four mutations cause the spontaneous formation of neuro-
serpin polymers that are retained as inclusion (or Collins)
bodies within neurons in the deeper layers of the cortex and
the substantia nigra [35, 55]. It can be responsible for the
occurrence of dementia, tremor, seizures, epilepsy and dys-
arthria that is present in diﬀerent degrees depending on the
harshness of the mutation involved. In heparin cofactor-
II, there are two known polymerization variants which are
Glu428Lys and Pro433Leu [56].
8.Polymeric ConformationsinSerpin
Loop A sheet polymeric structure is characterised by the
insertion of RCL of one serpin molecule into A β-sheet of
another between strand three and ﬁve [57]. Initial evidence
of this intermolecular linkage came from studies in which
α-1 antitrypsin polymerization was hindered by incubation
with peptides analogous to the RCL [49, 58] that was further
supported by ﬂuorescence energy transfer data [59]. In loop
C sheet polymer, one of the strand of C β-sheet moves away
to allow full insertion of the RCL and the position left vacant
by s1C is ﬁlled by the RCL of second molecule [35]. This
polymeric form is found in Mmalton variant of antitrypsin,
antithrombin can also forms similar type of polymer when
h e a t e di nt h ep r e s e n c eo fc i t r a t e[ 60]. s7A polymer has only
been shown in PAI-1, which is characterised by hydrogen
bonding of the RCL of one molecule with six strand of
the β-sheet A of the other, where donor RCL become the
seventh stand of the acceptor molecule’s A β-sheet [61]. In
disulﬁde linked polymeric form the RCL is not involved as
a polymer formation domain as it does in other polymeric
forms. Dimer α-1 antitrypsin has single cysteine residue
located on the B β-sheet and this dimeric species goes on
to form high order polymer. However, this disulﬁde-linked
polymer has similar linear morphology toboth loop A and C
sheet as supported by electron microscopy [62].
9.HelixB Variantsinthe ShutterRegion
The shutter region of serpins is comprised of a number of
well-conserved residues that play a signiﬁcant role in the
maintenance of stability and function [35]. Mutations in
shutter region allow the aberrant opening of the A-sheet,
with the likelihood of the insertion into its lower half of the
reactiveloopofanothermoleculetogiveintermolecularlink-
ageandpolymerization oftheserpin. Shutterregion includes
F-helix, B-helix, strand s3A and s5A of β-sheet A that plays
an important role in stability and function in serpins [55].
Conserved helix B residues interact with the β-sheet A at
the upper portion of the shutter region where RCL inserts as
s4A. Helix B mutationsin α-1-antichymotrypsin (Leu55Pro)
and α-1-antitrypsin (Phe51Leu, Ser53Phe and Val55Pro)
can cause lung (emphysema) and liver diseases (cirrho-
sis). Protein C-inhibitor (Ser52Phe and Ser54Leu) and
antithrombin (Pro80Ser/Thr, Thr85Met/Lys, Cys95Arg and
Leu99Phe) have mutations which can result in angioedema
and thrombosis [5, 25, 35, 56]. Importance of strand 6B
deformation and exposure of helix B in smooth insertion
of the reactive centre loop during serpin inhibition was
hypothesized recently and indicated that helix B exposure in
variants may increase its polymerization propensity [63].Journal of Amino Acids 7
F229L
G424R P429L
A382T
N187D
L99F
C95R
P80 S/T
T85 M/K
AntithrombinIII
(a)
V451M
P476S 
F455S
A436T
P54L
S52F
Cl-inhibitor
(b)
E354S/Q 
E342T
E264V
F51L
S53F
V55P
α-1 Antitrypsin
(c)
P228A
P229A
L55P
Antichymotrypsin
(d)
G392E
S49P
S52R
H338R      
Neuroserpin
(e)
E428K
Heparin cofactor-II
(f)
Figure 4: Point mutation in representative serpins that leads to latency, dimerization, aggregation and polymerization. Figure shows
diﬀerent serpin members like antithrombin(1e05), α-1antitrypsin (2qug),neuroserpin (1jjo),antichymotrypsin (4caa),heparincofactor-II
(1jmj) and C1-inhibitor along with corresponding natural variant that gives rise to polymerization. Images were prepared by using Pymol
visualizationtool.
10.AccessibleSurfaceAreaand Stability
Analysisof SerpinVariants
It is possible that the variants that contribute to serpin po-
lymerization are deeply buried and introduce local desta-
bilization. We took antithrombin, antitrypsin, antichymot-
rypsin, neuroserpin and heparin cofactor II as representative
inhibitoryserpins inwhichdetailsofpolymerization variants
are known and did an analysis of burial and stability. Table 4
shows the positions of the serpin variants along with their
ASA values. Analysis shows that in most cases the amino acid
involved in the polymerization was completely buried in the
native conformation. In the native state, antithrombin Pro-
80, Thr-85, Leu-99, antitrypsin Phe-51, Ser-53 and Val-558 Journal of Amino Acids
Table 4: Analysis of the residue burial and stability of natural
v a r i a n to fs e r p i ni n v o l v e di np o l y m e r i z a t i o n .
Serpins ASAb ΔΔGc
(Native) (kcal/mol)
Antithrombin-P80 S/Ta 0.0 −0.97, −0.72
Antithrombin-T85 M/Ka 2.9 −0.73, −3.04
Antithrombin-C95R 9.3 −1.33
Antithrombin-L99F 1.1 −1.03
Antithrombin-N187D 9.6 −1.92
Antithrombin-F229L 1.5 −0.92
Antithrombin-A382T 28.0 −0.33
Antithrombin-G424R 2.5 −1.30
Antithrombin-P429L 12.7 −0.18
Antitrypsin-F51L 0.0 −1.42
Antitrypsin-S53F 0.0 −0.42
Antitrypsin-V55P 2.6 −2.28
Antitrypsin-E264V 5.2 0.47
Antitrypsin-E342T 6.9 1.02
Neuroserpin-S49P 0.0 −1.19
Neuroserpin-S52R 0.0 −1.06
Neuroserpin-H338R 0.0 −1.37
Neuroserpin-G392E 0.0 −0.30
Antichymotrypsin-L55P 1.6 −2.17
Antichymotrypsin-P228A 4.9 −1.45
Heparin Cofactor-II-E428K 18.0 −0.22
aTwo diﬀerent variant at the same position.
bAccessible Surface Area (ASA) values were determined from DSSP algo-
rithm. The pdb codes used for the analysis are as follows: antithrombin
(1t1f), antitrypsin (1qlp), neuroserpin (1jjo and 3fgq), antichymotrypsin
(1yxa), and heparin cofactor-II (1jmj).
cΔΔG were determined for the variants by using Imutant 2.0 at pH 7.0 and
25◦C, the values were determined by using the diﬀerence of ΔG between the
wild-type and the polymerization variants mentioned in the table.
and neuroserpin Ser-49 and Ser-52 residues showed the
ASA value of zero, these residues are part of helix B. Helix
B residues tend to show the maximum burial especially the
residues that are conserved in the serpin.
To test the eﬀectofdeeplyburiedhelixBvariant ofserpin
on the overall stability point mutations were done using I
mutant2.0 program at temp 25◦C and pH 7.0 and the results
are summarized in Table 4. The results showed that all the
polymerizationvariantsofthehelixBweredestabilizingwith
ΔΔG values ranging from −0.4kcal/mole to −3.0kcal/mole.
No apparent correlation was found between the relative
burial and the magnitude of destabilization. Most destabi-
lized variants were not necessarily the most buried ones.
However the helix B residues like Thr-85 in antithrombin,
Val-55 in antitrypsin and Leu-55 in antichymotrypsin tend
to be more destabilized in comparison to other polymer-
ization variants in helix B. The result clearly indicates
that the deeply buried residues can cause conformational
ﬂexibility which results in the global destabilization in the
polymerizing variants of serpins.
11.Conclusion
Serpins fold into structures that are metastable and employ
a unique suicide substrate-like inhibitory mechanism to
achieve stable state. Serpins make use of many conserved in-
teractionslikedecreasingthesizeofsidechainsinoverpacked
regions, and increasing the size of cavities and ﬁlling of ex-
posed hydrophobic pockets to release the native strain to
convert from the native form to a cleaved inhibitory stable
conformation. Due to its inhibition mechanism serpin are
prone to conformational defects resulting in severe patho-
logical disorders. Understanding the mechanism of polymer
formationinserpinsisconfusingduetoavailabilityofseveral
models and also due to the lack of crystal structures of nat-
ural variants. Identifying speciﬁc domains and interactions
in serpin that contribute to inhibition and polymerization
mechanism is important. Helix B region is a mutation hot-
spotinserpinthatleadstopolymerizationduetodeepburial,
decreased stability and its involvement in RCL translocation.
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